Patents Assigned to UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY, LTD
  • Publication number: 20140010867
    Abstract: Methods employing chemiluminescent agents as therapeutically active agents in the treatment of proliferative disorders are disclosed. The chemiluminiscent agents are used in the disclosed method without a therapeutically effective amount of a photosensitizer. Novel chemiluminescent agents having the general formula: are also disclosed, wherein X, Y, Z, R3 and R5-R9 are as defined herein.
    Type: Application
    Filed: March 22, 2012
    Publication date: January 9, 2014
    Applicants: Ariel-University Research and Development Company Ltd., Semorex Technologies Ltd.
    Inventors: Bernard S. Green, Galia Luboshits, Michael A. Firer
  • Publication number: 20130285849
    Abstract: The invention, in some embodiments, relates to the field of global navigation satellite systems, and more particularly to the field of methods and devices for improving accuracy of position determination by receivers of global navigation satellite systems. Some embodiments of the invention relate to methods for generating a three-dimensional (3-D) representation of an urban area by a receiver of a global navigation satellite system using blocked lines of sight to satellites of the system. Additional embodiments of the invention relate to methods for transmitting a three-dimensional (3-D) representation of an urban area by a receiver of a global navigation satellite system for improving calculation of location by the global navigation satellite system receiver.
    Type: Application
    Filed: December 22, 2011
    Publication date: October 31, 2013
    Applicant: ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY, LTD.
    Inventors: Boaz Ben-Moshe, Harel Levi
  • Publication number: 20130190393
    Abstract: The described subject matter relates to the use of incensole, incensole acetate, and derivatives thereof, for the treatment, prevention or amelioration of diseases or conditions, including inflammatory-associated conditions; a disease or condition where neuroprotection is required; and a disease or condition selected from depression, anxiety, obsessive compulsive behaviors, deterioration in cognitive function, and deterioration in neurobehavioral function. Pharmaceutical compositions and method of treatment, prevention or amelioration of the above-mentioned diseases or conditions are also provided.
    Type: Application
    Filed: December 4, 2012
    Publication date: July 25, 2013
    Applicants: ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY LTD., YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD.
    Inventors: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD., ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY LTD.
  • Patent number: 8452084
    Abstract: A method for compressing an elevation map by means of digital image processing, according to which local and global parameters of an elevation map are calculated for sorting the elevation map into a corresponding category and the elevation map is categorized according to the calculated local and global parameters. Optimal parameters for compressing the elevation map are determined according to the calculated local and global parameters and according to the corresponding category and then the elevation map is compressed by applying on it digital image processing by using the determined optimal compression parameters.
    Type: Grant
    Filed: March 31, 2008
    Date of Patent: May 28, 2013
    Assignee: Ariel-University Research and Development Company Ltd.
    Inventors: Boaz Ben-Moshe, Liad Serruya, Arik Shamir
  • Publication number: 20130089085
    Abstract: Disclosed are methods and devices for wireless transmission of content using Wi-Fi infrastructure to multiple user-devices devices that does not require maintaining a Wi-Fi session with each user-device.
    Type: Application
    Filed: June 12, 2011
    Publication date: April 11, 2013
    Applicant: ARIEL UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY, LTD.
    Inventors: Boaz Ben-Moshe, Amit Dvir, Eyal Berliner
  • Publication number: 20120220537
    Abstract: N-substituted 9-aminoacridine and bis-acridino derivatives containing electron-withdrawing groups (EWG) or electron-donating groups (EDG), including amino acid residues, and one-pot methods for their synthesis are disclosed. The derivatives are potential candidates for cancer treatment.
    Type: Application
    Filed: November 1, 2010
    Publication date: August 30, 2012
    Applicant: ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY LTD.
    Inventor: Gary Gellerman
  • Publication number: 20120186383
    Abstract: Disclosed are an orientation controller based on a parallelogram linkage, a mechanical arm, an anthropomorphic gripper and components thereof such as mechanical digits suitable for use, for example, in the field of keyhole surgery.
    Type: Application
    Filed: September 21, 2010
    Publication date: July 26, 2012
    Applicant: UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY, LTD
    Inventors: Nir Schvalb, Boaz Ben Moshe, Alon Vardimon, Shamur Barak
  • Publication number: 20120076877
    Abstract: Disclosed are pharmaceutical compositions comprising extracts of Sarcopoterium spinosum, components of the extracts and uses of the pharmaceutical compositions as well as methods of making the compositions.
    Type: Application
    Filed: June 8, 2010
    Publication date: March 29, 2012
    Applicant: Ariel-University Research and Development Company. Ltd.
    Inventors: Tovit Rosenzweig, Zohar Kerem, Dvir Taler
  • Publication number: 20110022328
    Abstract: Disclosed is a method for determining an phase spectrum ?(?) of the complex spectral transfer function H(?) of a medium. In some embodiments, the method is applied for detecting or imaging an object screened by scattering medium or for determining a refractive index spectrum of a material.
    Type: Application
    Filed: February 8, 2009
    Publication date: January 27, 2011
    Applicant: Ariel-University Research And Development Company Ltd.
    Inventors: Er'el Granot, Shmuel Sternklar, Yosef Ben-Aderet
  • Patent number: 7772179
    Abstract: A method for destroying harmful cells is provided, applicable in treating proliferative diseases. The cells are destroyed by a combined treatment with a chemiluminescent agent and with a ligand-photosensitizer conjugate. The chemiluminescent agent emits light on reacting with oxygen species present in situ, the conjugate binds to the cell through its ligand and is activated by the emitted light, thereby destroying the cell. The method is demonstrated on a conjugate of transferrin-hematoporphyrin, which destroys cancerous cells in the presence of luminol.
    Type: Grant
    Filed: April 20, 2006
    Date of Patent: August 10, 2010
    Assignee: Ariel-University Research and Development Company Ltd.
    Inventors: Michael A. Firer, Raisa Laptev
  • Publication number: 20100099756
    Abstract: The described subject matter relates to the use of incensole, incensole acetate, and derivatives thereof, for the treatment, prevention or amelioration of diseases or conditions, including inflammatory-associated conditions; a disease or condition where neuroprotection is required; and a disease or condition selected from depression, anxiety, obsessive compulsive behaviors, deterioration in cognitive function, and deterioration in neurobehavioral function. Pharmaceutical compositions and method of treatment, prevention or amelioration of the above-mentioned diseases or conditions are also provided.
    Type: Application
    Filed: November 29, 2007
    Publication date: April 22, 2010
    Applicants: ARIEL-UNIVERSITY RESEARCH DEVELOPMENT COMPANY LTD.
    Inventors: Arik Moussaieff, Raphael Mechoulam, Ester Fride, Esther Shohami, Yinon Ben Neriah, Ruth Gallily
  • Publication number: 20090054306
    Abstract: A method for destroying harmful cells is provided, applicable in treating proliferative diseases. The cells are destroyed by a combined treatment with a chemiluminescent agent and with a ligand-photosensitizer conjugate. The chemiluminescent agent emits light on reacting with oxygen species present in situ, the conjugate binds to the cell through its ligand and is activated by the emitted light, thereby destroying the cell. The method is demonstrated on a conjugate of transferrin-hematoporphyrin, which destroys cancerous cells in the presence of luminol.
    Type: Application
    Filed: April 20, 2006
    Publication date: February 26, 2009
    Applicant: Ariel-University Research and Development Company Ltd.
    Inventors: Michael A Firer, Raisa Laptev